139 related articles for article (PubMed ID: 11159772)
1. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues.
Luo LY; Grass L; Howarth DJ; Thibault P; Ong H; Diamandis EP
Clin Chem; 2001 Feb; 47(2):237-46. PubMed ID: 11159772
[TBL] [Abstract][Full Text] [Related]
2. Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids.
Shaw JL; Grass L; Sotiropoulou G; Diamandis EP
Clin Biochem; 2007 Jan; 40(1-2):104-10. PubMed ID: 17045982
[TBL] [Abstract][Full Text] [Related]
3. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications.
Diamandis EP; Yousef GM; Soosaipillai AR; Grass L; Porter A; Little S; Sotiropoulou G
Clin Biochem; 2000 Jul; 33(5):369-75. PubMed ID: 11018688
[TBL] [Abstract][Full Text] [Related]
4. Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay.
Kapadia C; Chang A; Sotiropoulou G; Yousef GM; Grass L; Soosaipillai A; Xing X; Howarth DH; Diamandis EP
Clin Chem; 2003 Jan; 49(1):77-86. PubMed ID: 12507963
[TBL] [Abstract][Full Text] [Related]
5. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
[TBL] [Abstract][Full Text] [Related]
6. Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids.
Kishi T; Grass L; Soosaipillai A; Shimizu-Okabe C; Diamandis EP
Clin Chem; 2003 Jan; 49(1):87-96. PubMed ID: 12507964
[TBL] [Abstract][Full Text] [Related]
7. Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids.
Kishi T; Soosaipillai A; Grass L; Little SP; Johnstone EM; Diamandis EP
Clin Chem; 2004 Apr; 50(4):709-16. PubMed ID: 14764643
[TBL] [Abstract][Full Text] [Related]
8. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
[TBL] [Abstract][Full Text] [Related]
9. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
[TBL] [Abstract][Full Text] [Related]
10. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma.
Diamandis EP; Okui A; Mitsui S; Luo LY; Soosaipillai A; Grass L; Nakamura T; Howarth DJ; Yamaguchi N
Cancer Res; 2002 Jan; 62(1):295-300. PubMed ID: 11782391
[TBL] [Abstract][Full Text] [Related]
11. Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry.
Obiezu CV; Soosaipillai A; Jung K; Stephan C; Scorilas A; Howarth DH; Diamandis EP
Clin Chem; 2002 Aug; 48(8):1232-40. PubMed ID: 12142379
[TBL] [Abstract][Full Text] [Related]
12. Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients.
Zarghooni M; Soosaipillai A; Grass L; Scorilas A; Mirazimi N; Diamandis EP
Clin Biochem; 2002 May; 35(3):225-31. PubMed ID: 12074831
[TBL] [Abstract][Full Text] [Related]
13. Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids.
Obiezu CV; Shan SJ; Soosaipillai A; Luo LY; Grass L; Sotiropoulou G; Petraki CD; Papanastasiou PA; Levesque MA; Diamandis EP
Clin Chem; 2005 Aug; 51(8):1432-42. PubMed ID: 15961548
[TBL] [Abstract][Full Text] [Related]
14. Human kallikrein 10 expression in normal tissues by immunohistochemistry.
Petraki CD; Karavana VN; Luo LY; Diamandis EP
J Histochem Cytochem; 2002 Sep; 50(9):1247-61. PubMed ID: 12185203
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients.
Luo LY; Soosaipillai A; Grass L; Diamandis EP
Tumour Biol; 2006; 27(5):227-34. PubMed ID: 16864975
[TBL] [Abstract][Full Text] [Related]
16. Human kallikrein 10: a novel tumor marker for ovarian carcinoma?
Luo LY; Bunting P; Scorilas A; Diamandis EP
Clin Chim Acta; 2001 Apr; 306(1-2):111-8. PubMed ID: 11282101
[TBL] [Abstract][Full Text] [Related]
17. Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid.
Magklara A; Scorilas A; López-Otín C; Vizoso F; Ruibal A; Diamandis EP
Clin Chem; 1999 Oct; 45(10):1774-80. PubMed ID: 10508124
[TBL] [Abstract][Full Text] [Related]
18. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP
Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124
[TBL] [Abstract][Full Text] [Related]
19. Human kallikrein 10 ELISA development and validation in breast cancer sera.
Ewan King L; Li X; Cheikh Saad Bouh K; Pedneault M; Chu CW
Clin Biochem; 2007 Sep; 40(13-14):1057-62. PubMed ID: 17585892
[TBL] [Abstract][Full Text] [Related]
20. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
Luo LY; Katsaros D; Scorilas A; Fracchioli S; Bellino R; van Gramberen M; de Bruijn H; Henrik A; Stenman UH; Massobrio M; van der Zee AG; Vergote I; Diamandis EP
Cancer Res; 2003 Feb; 63(4):807-11. PubMed ID: 12591730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
